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Abstract
Backgroud: The Implantable Collamer Lens (ICL) has been used widely for refractive errors, We performed this
prospective randomized comparative study to compare postoperative intraocular pressure (IOP) and vaults of the
eyes implanted with conventional ICL and central hole ICL.
Methods: This study evaluated 44 eyes of 22 patients who underwent central hole ICL implantation in one eye and
conventional ICL implantation in the other eye by randomization assignment. noncontact intraocular pressure were
performed on 6 h, 1 day, 3 days, 1 week, 2 weeks, 1 month, 3 months and 6 months, while ICL vaults were
measured on 1 day, 1 week, 1 month and 6 months.
Results: The IOP of both eyeswithcentral hole and conventional ICLrosetemporarily during the first month after
surgeries, especially on 1 day and 2 weeks points postoperatively. The IOP ofeyes with central hole ICL was higher
than that of conventionl ICL. The vaults ofeyes with central hole and conventional ICL decreased slightly with time
but did not significantly affect the postoperative IOP.
Conclusions: Despite the sensitivity of viscoelastic agents or inflammation, this newly developed central hole ICL
implantation appears to be equivalent in safty and effcacy to conventional ICL implantation for the correction of
ametropia.
Trial registration: Current Controlled Trials ChiCTR-INR-16008896. Retrospectively registered 24 July 2016.
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Background
The Visian Implantable Collamer Lens (ICL) (STAAR
Surgical Co.), a posterior chamber phakic intraocular
lens (PIOL), has been reported to perform well for the
correction of moderate to high ametropia [1–4]. How-
ever, in order to reduce the occurrence of pupillary
block, this surgical technique requires preoperative laser
iridotomy or intraoperative peripheral iridectomy, which
is sometimes accompanied with iris hemorrhage, inflam-
mation, or cataract [5]. Despite these additional procedures,
some studies described cases of pupillary block, possibly
because of the closure of previously iridotomies attributable
to chronic inflammatory responses [6–8]. Moreover, the
risk of cataract formation is presumed resulting from direct
physical contact between the ICL and the crystalline lens
or from malnutrition attributable to poor circulation of the
aqueous humor [9].
Recently, the V4c Visian ICL (STAAR Surgical Com-
pany, Monrovia, California, USA) was designed with a 360
mm central hole to allow aqueous humor to flow which
did not require additional peripheral iridotomies, and may
reduce the risk for cataract formation [10]. Earlier studies
have demonstrated that the V4c ICL has shown compar-
able refractive results to the conventional V4b ICL with-
out central hole in vitro and in vivo experiments [11–13].
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Considering that the presence of the central artificial
hole induces a change in the aqueous humor dynamics
[14], the central hole may affect the intraocular pressure
(IOP) and the vault of ICL, which play a vital role in de-
termining the safety of the ICL implantation technique.
Although several studies have reported the IOP changes
after implantation of v4c ICL, most of them described
the situations in the middle or late stage postoperatively
and are not in great detail [15, 16]. Moreover, the vault
is a possible source of IOP changes, and it is uncertain
whether there is any correlation between them in v4c
implanted eyes. Therefore, in this prospective and ran-
dom study, we examine and compare the IOP and vaults
in the eyes with v4b and v4c ICL early postoperatively,
then make further efforts to find out the relationship be-
tween IOP and vaults.
Methods
This prospective randomized controlled trial was per-
formed in Ophthalmological Institute of Cangzhou cen-
tral hospital (Hebei, China) from January, 2016 to June,
2016. The study followed the tenets of the Declaration
of Helsinki and was approved by an institutional review
board. Written informed consent was obtained from all
patients after they received a full explanation of the na-
ture and possible consequences of the study.
Patients were selected following these inclusion criteria:
a corrected distance visual acuity (CDVA) of 20/40 or bet-
ter, stable bilateral myopia for at least 2 years, refractive
error in the correctable range (from -0.50 to -18.00 diop-
ters [D]), and a clear central cornea. The exclusion criteria
included age younger than 20 years, anterior chamber
depth (ACD) ≤3.0 mm, endothelial cell density (ECD) ≤
2000 cell/mm2, mesopic pupil > 7.0 mm, cataract, history
of glaucoma or other ophthalmic diseases.
Each patient underwent bilateral implantation of the pos-
terior chamber phakic implantable Collamer lens with and
without a 0.36-mm central artificial hole (central hole ICL
V4c and conventional ICL V4b, STAAR Surgical) for the
correction of moderate to high myopia by the same surgeon
(Fan Yuxiang). The order of the two methods and the eye
treated were randomized using a random number table at
the inclusion visit. Using an envelope technique, the patients
and examiners were masked to the types of ICLs implanted.
Forty four eligible eyes of 22 patients (9 men and 13
women) were involved in this study. This sample size of-
fered 90% statistical power at the 5% level in order to
detect a 2.0 mmHg difference in intraocular pressure be-
tween the 2 groups, when the standard deviation (SD) of
the mean difference was 2.0 mmHg.
Preoperative assessment
Before ICL implantation, patients underwent a series of
ophthalmologic tests including uncorrected distance visual
acuity (UDVA), corrected distance visual acuity (CDVA),
manifest and cycloplegic refractions, slit-lamp examin-
ation, IOP measurement (noncontact tonometer, NCT
Nidek Co, Ltd, Japan), Central corneal thickness (ultra-
sound pachymetry), ECD measurement, ultrasound bio-
microscope (UBM), and dilated fundus examination. All
eyes were targeted for emmetropia. ICL power calcula-
tion was performed according to the manufacturer’s in-
structions using a modified vertex formula. The size of
the ICL was selected based on the horizontal white-to-
white diameter measured by a metal caliper, and the
anterior chamber depth was measured by scanning-
slit topography (Pentacam; Oculus GmbH, Wetzlar,
Germany).
Surgical procedures
Peripheral iridotomies were performed at the 10:30 and
1:30 clock positions using a neodymium-doped yttrium-
aluminum-garnet (Nd:YAG) laser for eyes scheduled to
receive the V4b ICL, and eyes planned for V4c ICL im-
plantation were exempt from this procedure. Both eyes of
each patient underwent the same procedure. One fixed op-
erator gave every eye pilocarpine drops, surface anesthesia,
put on iridotomy contact len, then the laser was activated
at a setting of 200 to 250mW on the V4b eye while 0mW
on the V4c eye. The patients were uncertain which eye got
laser iridotomy. Sixty minutes before surgery, pupils were
dilated with dilating and cycloplegic agents. Under topical
anesthesia, a model V4 ICL (central hole or conventional
ICL) was inserted through a 3.0 mm clear corneal incision
with the use of an injector cartridge (STAAR Surgical Co.)
after injection of viscoelastics (Healon; Abbott Medical Op-
tics, Santa Ana, California, USA) into the anterior cham-
ber. The ICL was placed in the posterior chamber, and
then viscoelastics was washed out of the anterior chamber
with balanced salt solution, followed by instillation of
miotic agent. After surgery, antibiotic (0.5% Levofloxacin
Eye Drops, Santen Pharmaceutical Co.,Ltd) and steroidal
(Tobramycin and Dexamethasone Eye Drops, Alcon NV)
drugs were administered topically 4 times daily for 10 days
and then gradually tapered.
Postoperative assessment
Postoperative examinations of noncontact intraocular pres-
sure were performed on 6 h, 1 day, 3 days, 1 week, 2 weeks,
1 month, 3 months and 6 months, while ICL vaults were
measured on 1 day, 1 week, 1 month and 6 months. The
evaluations of uncorrected distance visual acuity, best-
corrected distance visual acuity and manifest refraction
were also carried out. The examiners were only respon-
sible for the examination of objective indicators without
direct communications with patients.
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Statistical analysis
Data were analyzed using SPSS software (version 19.0,
SPSS, Inc.). The results are expressed as mean ± standard
deviation. The Wilcoxon signed rank test was used for
statistical analysis to compare the differences between the
2 groups, and between preoperative and postoperative data
in each group. One-way analysis of variance (ANOVA)
was used to evaluate the changes over time. Meanwhile,
the correlation between IOP and vaults was analyzed by
Pearson correlation coefficient. A value of P < 0.05 was
considered statistically significant.
Results
The study sample comprised 44 eyes of 22 patients (9
men and 13 women). Table 1 shows the preoperative
demographic characteristics and ICL parameters. Eyes had
a baseline preoperative spherical equivalent (SE) of -9.64 ±
5.02 (-4.75,-15.75). 6 months after surgery, the SE was
-0.50 ± 0.22 (-0.25,-1.00). At this time, 40(90.9%) eyes had
an uncorrected distance visual acuity (UDVA) that was
equal to or better than the preoperative corrected distance
visual acuity(CDVA). One month after surgery while 44
(100%) eyes had a CDVA that was equal to or better than
the preoperative CDVA. No eye lost 2 or more lines of
CDVA. All surgical procedures were uneventful, and no
postoperative complications such as cataract formation,
pigment dispersion syndrome, papillary block, or axis rota-
tion were seen during the 6-month observation period.
The mean IOP of all eyes was 14.4 ± 1.8 mmHg (range
10.2–17.9 mmHg) before surgery. Postoperatively, the
IOP level of two groups both shot up and reached the
peak at 6 h, then decreased gradually until 1 week, follow-
ing by a small increase on 2 weeks, declined to nearly pre-
operative levels on 1 month, at last maintained steadily
during 1 to 6 months (Fig. 1). In conventional ICL (v4b)
group, Postoperative IOP was higher than preoperative
level except 1 month point. While in central hole ICL
(v4c) group, Postoperative IOP was higher than preopera-
tive level except 3 month point. As shown in Table 2, the
mean IOP was 19.6 ± 3.4mmHg and 21.1 ± 3.5mmHg in
the V4b and V4c group, respectively at 6 h postoperatively
(P = 0.020). Meanwhile, on 1 day postoperatively, the
mean IOP was 18.2 ± 2.0mmHg and 19.7 ± 2.9mmHg in
the V4b and V4c group (P = 0.023). The IOP level in v4c
group is a bit higher than that in v4b group, and these dif-
ferences were statistically significant. However, there were
no significant differences between the two groups at other
follow-up visits (P > 0.05).
The changes of the central hole and conventional ICL
vaults with time are illustrated in Table 3. The differ-
ences between the two groups were not statistically sig-
nificant at any time point after surgery. As shown in
Fig. 2, the vaults in both groups displayed a mildly
downward trend over time, but the variance was not sta-
tistically significant (P = 0.464 in v4b group, P = 0.330 in
v4c group). Furthermore, there were no statistically
Table 1 Preoperative patient demographics in eyes undergoing
implatation of V4b or V4c implantable collamer lenses
Demographic V4b V4c P











-0.84 ± 1.05(0,-2.50) -0.73 ± 0.71(0,-2.25) 0.673
UDVA (logMAR) 1.35 ± 0.23(1.00,2.00) 1.34 ± 0.22(1.00,2.00) 0.416
CDVA (logMAR) -0.02 ± 0.04(-0.30,0.08) -0.03 ± 0.05(-0.30,0.08) 0.807
White to
white(mm)
11.8 ± 0.8(10.5-12.2) 11.7 ± 0.8(10.5-12.2) 0.476
Anterior chamber
depth (mm)
3.43 ± 0.33(3.00-3.69) 3.42 ± 0.31(2.90-3.68) 0.761
ICL size (mm) 12.5 ± 0.8(11.0-13.0) 12.4 ± 0.8(11.0-13.0) 0.812
Fig. 1 Time course of intraocular pressure changes in the perioperative
period. The bars represent SD
Table 2 Intraocular pressure (IOP) before and after the
implantation of v4b and v4c ICL (X ± SD)
IOP(mmHg) V4b P1 V4c P2 Z P3
Pre 14.3 ± 1.8 14.5 ± 1.8 -1.271 0.204
6h 19.6 ± 3.4 0.000 21.1 ± 3.5 0.000 -2.329 0.020*
1d 18.2 ± 2.0 0.000 19.7 ± 2.9 0.000 -2.273 0.023*
3d 16.1 ± 2.4 0.003 16.7 ± 1.9 0.001 -0.958 0.338
1w 16.0 ± 1.7 0.003 15.6 ± 2.0 0.032 -0.779 0.436
2w 18.1 ± 2.2 0.000 18.0 ± 2.3 0.000 -0.417 0.676
1m 14.6 ± 1.7 0.399 15.7 ± 1.4 0.014 -1.901 0.057
3m 16.1 ± 2.2 0.001 15.6 ± 2.1 0.074 -0.520 0.603
6m 15.7 ± 2.4 0.009 16.0 ± 2.2 0.009 -0.422 0.673
P1: p value between preoperative intraocular pressure and postoperative
intraocular pressure at different follow-up visits in V4b group
P2: p value between preoperative intraocular pressure and postoperative
intraocular pressure at different follow-up visits in V4c group
P3: p value of intraocular pressure between V4b group and V4c group at
different time points, *p <0.05
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significant correlations between the vaults and the
IOP level in v4b group (Spearman correlation coeffi-
cient r = -0.007, P = 0.948) and v4c group (Spearman
correlation coefficient r = 0.081, P = 0.454). (Fig. 3).
Discussion
This trial was planned to find out the IOP changes and
its correlation with vaults of central hole v4c ICL and
conventional V4b ICL. A bilateral design, with similar
myopia in both eyes of a given patient, comparing v4b
ICL in one eye with v4c ICL in the other eye seemed to
satisfy the criteria. Indeed, this preoperative, randomized
study largely decreased the variability introduced by in-
terindividual differences and differences in surgeons that
linked to outcome measures. It also allowed a better
statistical evaluation with each patient serving as his
own control. Moreover, the patients and examiners were
masked to the types of ICLs implanted, in order to re-
duce the information bias and subjective bias. Thus, for
an identical number of cases, this methodology allowed
us to define small quantitative differences more clearly.
Furthermore, concerning the important problem of risks
for the patient, because the long-term outcome of both
ICL was unknown, our choice of performing a bilateral
study balanced the potential risk for the patient.
In present study, we observed an increase IOP during
the first month postoperatively with two transient peaks
on the first 1 day and at approximately 2 weeks in both
v4b and v4c groups. 11 eyes had an IOP over 22 mm Hg
(4 in v4b group and 7 in v4c group) at 6 h and 4 eyes
(all in v4c group) on 1 day point. The mean IOP of v4c
group is significantly higher than that of v4b group at 6
h and 1 day postoperatively. However, there was no stat-
istical difference between the vaults of the two groups
on 1 day, and no chronically elevated IOP levels or pap-
illary block were observed in any group. It demonstrated
that the evaluated IOP was not caused by vault differ-
ence. In another study, Gonzalez-Lopez [17] found that
obstruction of the trabecular meshwork or even of the
central hole by residual viscoelastic material may be the
main cause of this increase. Postoperative trabeculitis
may also have affected early changes in IOP. Neverthe-
less, the reduction of surgical trauma and intraoperative
time limited the degree of impact of the inflammation
on IOP. In our study, the two groups had the similar
ocular conditions and the same surgical equipmensts,
which obviously reduced the interference of other factors.
Therefore, we consider the fluid circulation function of
central hole is less effective than that of peripheral iris in-
cision, especially when the aqueous humor is mixed with
the viscoelastic agent or a lot of inflammatory cells and
pigments. After all, compared with the iris incision, the
diameter of the central hole is smaller, and the number is
only one.
During 3 days–6 months, the IOP in two groups
showed an analogous trend and had no significant differ-
ence statistically. 1 eye had an IOP over 22 mmHg in
each group on 2 weeks point requiring temporary topical
hypotensive treatment. Consistent with other studies
[18, 19], we attribute the increase in IOP during the first
month after surgery to the effect of postoperative in-
flammation and topical steroids. As we use Tobramycin
and Dexamethasone Eye Drops 4 times daily for 10 days,
this steroid-related increases in IOP were most obviously
2 weeks after surgery correspondingly. Furthermore,
with the decrease of the dosage of the drug and the in-
traocular inflammation, the IOP gradually went down to
nearly preoperatively level. At the end of our study, only
Table 3 Lens vaults after the implantation of v4b and v4c ICL
(X ± SD)
Vaults(μm) V4b V4c P
1d 567.2 ± 54.3 568.5 ± 51.9 0.626
1w 565.5 ± 47.7 560.2 ± 50.4 0.111
1m 554.1 ± 47.3 549.6 ± 50.0 0.121
6m 546.6 ± 46.7 542.8 ± 45.3 0.085
P: p value of the vaults between V4b group and V4c group at different
time points
Fig. 2 Time course of the vault changes after implantation of v4b
and v4c ICL
Fig. 3 Correlation of the vault and intraocular pressrue after implantation
of v4b and v4c ICL
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1 eye had more than a 5 mmHg increase in IOP over
the preoperative value (from 11.8 to 17.4 mmHg). How-
ever, this increases was not considered clinically relevant.
After topical steroid treatment, no eye required further
hypotensive treatment to maintain IOP. Thus, it can be
seen that the effects of conventional drugs and mild inflam-
mation are proximal on v4b and v4c ICL. Despite the ab-
sence of peripheral iridotomy, normal aqueous flow seems
to occur as a result of the central hole. Hence, the new V4c
ICL could maintain physiologic IOP levels under normal
circumstances during the follow-up period.
The results of vaults in this study showed that in both
central hole ICL and conventional ICL groups, vaults
over the crystalline lens decreased slightly over time, al-
though the variance was not statistically significant. And
there were no significant between-group differences in
the amount of vaults at any timepoint after surgery, sug-
gesting that the time course of the central hole ICL vault
is essentially equivalent to that of the conventional ICL.
Kazutaka Kamiya’s findings were in line with our results
in that there was a trend toward a decrease in the vault
over time. Age-related increase in the thickness of the
crystalline lens and the fixed position of the pIOL hap-
tics may account for this slight decrease with time in the
vault [20]. Hun Lee’s study also demonstrated that dy-
namic movement of the conventional and V4c ICL
occur coincidentally with crystalline lens and anterior
segment changes during the act of accommodation [21].
Therefore, the presence of an artificial hole does not sig-
nificantly affect the amount of the vault. There are many
factors affecting IOP. However, our results showed no sig-
nificant correlation between the vault and the IOP, not
only in eyes with v4b ICL but also in those with v4c ICL.
One main concern about the Visian V4c pIOL is the
possibility of pupillary block caused by obstruction of
the central hole which would affect IOP extremely. But
no cases of pupillary block were observed in our study.
The limitation of this study is that the sample data were
limited. Only by increasing the number of implantions
will we know whether the central hole ensures the free
flow of aqueous humor in all possible clinical situations.
Conclusion
Our comparative study demonstrated that the IOP of
both central hole and conventional ICL evaluated tem-
porary during the first month after surgeries, especially
on 1 day and 2 weeks postoperatively. The IOP of cen-
tral hole ICL was higher than that of conventionl ICL,
indicating that the former is more vulnerable to visco-
elastic agent or aqueous humor turbidity. In addition,
the vaults of central hole and conventional pIOL de-
creased slightly with time and did not significantly affect
the IOP postoperatively. Although longer observation in
a large number of patients is required to assess the long-
term qulity of this new ICL model, we agree with other
authors [12, 16, 22] that this new surgical approach,
which does not require additional iridectomies, is a safe
and effective alternative to conventional ICL. Another
advantage was that iridotomies were not needed because
of the new ICL V4c design. Its drainage deficiencies may
be made up possibly by meliorations.
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